Press Release
Mediplus CT3000 Cuff Machine has been submitted for evaluation by The National Coordinating Centre for Health Technology Assessment (NCCHTA).
23rd September 2005
Launched earlier in the year, The CT3000 – Non-Invasive Bladder Analysis for Men, has been identified by the National Horizons Scanning Centre (NHSC) and subsequently the National Coordinating Centre for Health Technology Assessment (NCCHTA) for evaluation.
Using the clinical evidence developed by The Freeman Hospital and The Bristol Urological Institute and the available Government statistics on costs associated with the treatment of men with LUTS, the CT3000 has the potential to save the NHS tens of millions of pounds, thousands of hours clinical time, reduce the number of operations required by Men per annum and improve their clinical outcome from the operation.
About Mediplus – Mediplus Limited is a privately owned company that began trading in 1986. It is a manufacturer of specialist medical disposables for the hospital market where it's main areas of interest are in Urology and Gastroenterology. The company's line of urodynamics catheters, pump tube sets and accessories are the market leader in the UK, and the company exports to many countries world-wide. The company has a comprehensive line of Manometry and pH catheters for Gastroenterology. In addition, Mediplus successfully distributes and markets theatre disposables and capital equipment for several USA and European manufacturers.
About NCCHTA - The National Coordinating Centre for Health Technology Assessment (NCCHTA), handles the secretariat for the ACTS group on behalf of the Department of Health. ACTS has a membership drawn from health departments, NICE, patient/carer/consumer groups, professional groups, universities and industry. The Committee's assessment is based on a discussion of Briefing Notes on individual topics, together with the comments of reviewers, after which it makes recommendations to ministers on which topics should be referred to NICE. |
